LimmaTech Biologics AG is a clinical stage biopharmaceutical company. We are a science-driven firm focused on the development and manufacture of next generation pharmaceuticals. We are at the forefront of in vivo carbohydrate engineering. LimmaTech applies its expertise in translating novel scientific concepts into early proof of concepts for the prevention of life-threatening diseases.

We develop vaccines together with GlaxoSmithKline plc under an exclusive research and development agreement and conduct our own proprietary research.